223 related articles for article (PubMed ID: 24823697)
1. MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.
Jia AY; Castillo-Martin M; Bonal DM; Sánchez-Carbayo M; Silva JM; Cordon-Cardo C
Br J Cancer; 2014 Jun; 110(12):2945-54. PubMed ID: 24823697
[TBL] [Abstract][Full Text] [Related]
2. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
3. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
[TBL] [Abstract][Full Text] [Related]
4. Predicting progression of bladder urothelial carcinoma using microRNA expression.
Rosenberg E; Baniel J; Spector Y; Faerman A; Meiri E; Aharonov R; Margel D; Goren Y; Nativ O
BJU Int; 2013 Nov; 112(7):1027-34. PubMed ID: 23387295
[TBL] [Abstract][Full Text] [Related]
5. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
Caporali S; Amaro A; Levati L; Alvino E; Lacal PM; Mastroeni S; Ruffini F; Bonmassar L; Antonini Cappellini GC; Felli N; Carè A; Pfeffer U; D'Atri S
J Exp Clin Cancer Res; 2019 Jun; 38(1):272. PubMed ID: 31227006
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-140 represses glioma growth and metastasis by directly targeting ADAM9.
Liu X; Wang S; Yuan A; Yuan X; Liu B
Oncol Rep; 2016 Oct; 36(4):2329-38. PubMed ID: 27498787
[TBL] [Abstract][Full Text] [Related]
7. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.
Chen W; Lu Q; Li S; Zhang X; Xue X
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33146718
[TBL] [Abstract][Full Text] [Related]
8. MiR-126 inhibits cell migration and invasion by targeting ADAM9 in oral squamous cell carcinoma.
Qin WJ; Lv LH; Zhang M; Zhou X; Liu GQ; Lu HJ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10324-10331. PubMed ID: 31841187
[TBL] [Abstract][Full Text] [Related]
9. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
Wang FF; Wang S; Xue WH; Cheng JL
Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
11. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
12. Relevance of A Disintegrin and Metalloproteinase Domain-Containing (ADAM)9 Protein Expression to Bladder Cancer Malignancy.
Moriwaki M; Le TT; Sung SY; Jotatsu Y; Yang Y; Hirata Y; Ishii A; Chiang YT; Chen KC; Shigemura K; Fujisawa M
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740916
[TBL] [Abstract][Full Text] [Related]
13. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH
Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884
[TBL] [Abstract][Full Text] [Related]
15. ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis.
Chiu KL; Lin YS; Kuo TT; Lo CC; Huang YK; Chang HF; Chuang EY; Lin CC; Cheng WC; Liu YN; Lai LC; Sher YP
Oncotarget; 2017 Jul; 8(29):47365-47378. PubMed ID: 28537886
[TBL] [Abstract][Full Text] [Related]
16. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z
Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063
[TBL] [Abstract][Full Text] [Related]
17. miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Luo S; Xie J
Oncol Rep; 2017 Jan; 37(1):123-130. PubMed ID: 27878272
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circNINL promotes breast cancer progression through activating β-catenin signaling via miR-921/ADAM9 axis.
Xu C; Yu H; Yin X; Zhang J; Liu C; Qi H; Liu P
J Biochem; 2021 Sep; 169(6):693-700. PubMed ID: 33479730
[TBL] [Abstract][Full Text] [Related]
19. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of microRNAs in bladder cancer.
Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
